Skip to main content
MedPathMedPath Home
Clinical Trials/RPCEC00000217
RPCEC00000217
Not yet recruiting
Phase 3

Comparative study of medium-term effects of D-004 and terazosin in patients with benign prostatic hyperplasia

Centre of Natural Products/National Centre for Scientifc Research0 sites100 target enrollmentSeptember 30, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBenign Prostatic HyperplasiaLower urinary tract symptomsProstatic HyperplasiaProstatic DiseasesGenital Diseases, MaleMale Urogenital Diseases

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Benign Prostatic Hyperplasia
Sponsor
Centre of Natural Products/National Centre for Scientifc Research
Enrollment
100
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2016
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Centre of Natural Products/National Centre for Scientifc Research

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients \>\= 50 years old \<\=80 years old
  • •2\. Informed consent
  • •3\. IPSS score between \>\=7, \< 19
  • •4\. Enlarged prostate checked by rectal examination

Exclusion Criteria

  • •1\. Prostate Cancer.
  • •2\. Prior urological surgery.
  • •3\. Urinary retention.
  • •4\. Urinary tract infection.
  • •5\. Criteria to be catheterized in next 3 months.
  • •6\. PSA\> 5 ng / mL .
  • •7\. Acute myocardial infarction, stroke, transient ischemic attack or major surgery within 6 months previous.
  • •8\. History of heart failure.
  • •9\. History of hepatic failure.
  • •10\. Blood Pressure \> 180/110 mm Hg.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
D-004 in patients with Bening Prostatic HyperplasiaBenign Prostatic Hyperplasia
RPCEC00000138atural Products Center (CPN)100
Recruiting
Phase 3
Side effects of Duloxetine plus Electroconvulsive therapy in depressioTreatment resistance depression diagnosed by psychiatrist based on DSM5 criteria.Severe depressive episode without psychotic symptoms
IRCT20181204041847N1Shiraz University of Medical Sciences32
Completed
Not Applicable
A 4-period study to investigate the effects of d-amphetamine on psychomotor function in relation to dopamine release capacity in healthy male subjectsmethod development for further drug researchmethod development
NL-OMON38881Centre for Human Drug Research16
Recruiting
Not Applicable
A prospective clinical study of the influence of donor nephron mass index on graft function after kidney transplantatioN18.4N18.5Chronic kidney disease, stage 4Chronic kidney disease, stage 5
DRKS00006197Klinik für Allgemein- und Viszeralchirurgie, Goethe Universität100
Completed
Phase 2
A Comparative Study on the Effect of Prescribing Dexmedetomidine with Haloperidol in Preventing Delirium?Delirium.Other delirium Delirium of mixed origin Postoperative delirium
IRCT20171104037209N1Esfahan University of Medical Sciences100